Pilot Study for the Evaluation of the Safety and the Feasibility of Treatment Simplification to Atazanavir/Ritonavir + Lamivudine in Patients Stably Treated With Two NRTIs + Atazanavir/Ritonavir With Optimal Virologic Response.
Phase of Trial: Phase IV
Latest Information Update: 03 Aug 2016
At a glance
- Drugs Atazanavir (Primary) ; Lamivudine (Primary) ; Nucleoside reverse transcriptase inhibitors; Ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms AtLaS
- 10 Jun 2017 Biomarkers information updated
- 24 Mar 2012 Status changed from not yet recruiting to completed as reported European Clinical Trials Database.
- 24 Apr 2009 New trial record